Related Experiment Video
Updated: Jul 23, 2025

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
Published on: April 6, 2012
An epigenetic modulator with promising therapeutic impacts against gastrointestinal cancers: A mechanistic review on
Amirhossein Davoodvandi1, Mahdi Rafiyan2, Zatollah Asemi2
1Cancer Immunology Project (CIP), Universal Scientific Education and Research Network (USERN), Tehran, Iran; Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, I.R. Iran.
Abstract:
Due to their high prevalence, gastrointestinal cancers are one of the key causes of cancer-related death globally. The development of drug-resistant cancer cell populations is a major factor in the high mortality rate, and it affects about half of all cancer patients. Because of advances in our understanding of cancer molecular biology, non-coding RNAs (ncRNAs) have emerged as critical factors in the initiation and development of gastrointestinal cancers. Gene expression can be controlled in several ways by ncRNAs, including through epigenetic changes, interactions between microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) and proteins, and the function of lncRNAs as miRNA precursors or pseudogenes. As lncRNAs may be detected in the blood, circulating ncRNAs have emerged as a promising new class of non-invasive cancer biomarkers for use in the detection, staging, and prognosis of gastrointestinal cancers, as well as in the prediction of therapy efficacy. In this review, we assessed the role lncRNAs play in the progression, and maintenance of colorectal cancer, and how they might be used as therapeutic targets in the future.
Insights
Long non-coding RNAs (lncRNAs) are key in gastrointestinal cancers. These molecules show promise as non-invasive biomarkers for early detection, prognosis, and guiding therapy in patients.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Gastrointestinal cancers are a leading cause of cancer death worldwide.
- Drug resistance in cancer cells significantly contributes to high mortality rates.
- Non-coding RNAs (ncRNAs) are increasingly recognized for their role in cancer development.
Purpose of the Study:
- To review the role of long non-coding RNAs (lncRNAs) in gastrointestinal cancer progression.
- To explore the potential of lncRNAs as therapeutic targets.
- To highlight the utility of circulating ncRNAs as non-invasive biomarkers.
Main Methods:
- Literature review focusing on lncRNAs in gastrointestinal cancers.
- Analysis of ncRNA regulatory mechanisms (epigenetic, miRNA interactions).
- Assessment of lncRNAs in blood for biomarker potential.
Main Results:
- lncRNAs play critical roles in the initiation, development, and maintenance of gastrointestinal cancers.
- lncRNAs regulate gene expression through various mechanisms, including epigenetic modifications and miRNA interactions.
- Circulating lncRNAs are detectable in blood and show potential as non-invasive biomarkers.
Conclusions:
- lncRNAs are crucial in gastrointestinal cancer biology and progression.
- lncRNAs represent promising therapeutic targets for gastrointestinal cancers.
- Circulating lncRNAs offer a novel avenue for non-invasive cancer diagnostics and prognostics.
Related Concept Videos
MicroRNAs
Epigenetic Regulation
X-chromosome...
Microorganisms in Medicine and Therapeutics
Mitogens and the Cell Cycle
Targeted Cancer Therapies
There are several types of targeted therapies against...

